Outcome of Chinese patients with hepatitis B at 96 weeks after functional cure with IFN versus combination regimens-Reference-Cited by-同舟云学术

Outcome of Chinese patients with hepatitis B at 96 weeks after functional cure with IFN versus combination regimens

Published:2021-02-16 Issue:7 Volume:41 Page:1498-1508
ISSN:1478-3223
Container-title:Liver International
language:en
Short-container-title:Liver Int

Author:

Pan Calvin Q.¹²^ORCID,Li Ming‐Hui³⁴^ORCID,Yi Wei⁵^ORCID,Zhang Lu³^ORCID,Lu Yao³^ORCID,Hao Hong‐Xiao³,Wan Gang⁶,Cao Wei‐Hua³,Wang Xing‐Yue³,Ran Chong‐Ping³,Shen Ge³,Wu Shu‐Ling³,Chang Min³,Gao Yuan‐Jiao³,Xie Yao³⁴^ORCID

Affiliation:

1. Center of Liver Diseases Beijing Ditan Hospital Capital Medical University Beijing China

2. Division of Gastroenterology and Hepatology Department of Medicine NYU Langone Health, New York University School of Medicine New York NY USA

3. Department of Hepatology Division 2 Beijing Ditan Hospital Capital Medical University Beijing China

4. Department of Hepatology Division 2 Peking University Ditan Teaching Hospital Beijing China

5. Department of Obstetrics and Gynecology Beijing Ditan Hospital Capital Medical University Beijing China

6. Department of Medical and Biological Statistics Beijing Ditan Hospital Capital Medical University Beijing China

Publisher

Wiley

Subject

Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/liv.14801

Reference23 articles.

1. Tenofovir to Prevent Hepatitis B Transmission in Mothers with High Viral Load

2. Natural History and Clinical Consequences of Hepatitis B Virus Infection

3. An expert consensus for the management of chronic hepatitis B in Asian Americans

4. Long-term therapy with nucleoside/nucleotide analogues for chronic hepatitis B in Asian patients

5. HBsAg loss after peginterferon-nucleotide combination treatment in chronic hepatitis B patients: 5 years of follow-up

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Quantitative hepatitis B core antibody and quantitative hepatitis B surface antigen: Novel viral biomarkers for chronic hepatitis B management;World Journal of Hepatology;2024-04-27

2. Peg-IFNα combined with hepatitis B vaccination contributes to HBsAg seroconversion and improved immune function;Virology Journal;2024-03-30

3. Prediction model for hepatitis B e antigen seroconversion in chronic hepatitis B with peginterferon-alfa treated based on a response-guided therapy strategy;World Journal of Hepatology;2024-03-27

4. Relationship between Phenotypic Changes of Dendritic Cell Subsets and the Onset of Plateau Phase during Intermittent Interferon Therapy in Patients with CHB;BIOMED ENVIRON SCI;2024

5. Comparison of the Clinical Curative Efficacy of Interferon Monotherapy and Combined with Nucleotide Analogues in the Treatment-Naive Patients with Chronic Hepatitis B;Advances in Clinical Medicine;2024